About Lozen Pharma Private Limited
Data last updated:
Lozen Pharma Private Limited is a private limited company based in Savanur, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2009PTC068381. Its GSTIN is 29AABCL5669C1ZD (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹37.55 Cr. It is led by directors including Arjun Gautam Ashra and Gautam Rasiklal Ashra.
Its last annual general meeting (AGM) was held on 25 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kssidc Industrial Estate Shiggaon Road, Savanur, Karnataka, India – 581118.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.38 Cr. For the same year it recorded a net profit of ₹1.05 Cr (net margin 2.2%) and EBITDA of ₹4.18 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 45% over five years.
The company has about 88 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lozen Pharma. As per MCA filings, the company has open charges of ₹13.98 Cr and satisfied charges of ₹1.45 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lozenpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressKssidc Industrial Estate Shiggaon Road, Savanur, Karnataka, India – 581118
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Lozen Pharma Private Limited
Lozen Pharma has one previous CIN (Corporate Identification Number): U24239MH2009PTC189566. The current CIN is U24239KA2009PTC068381, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239KA2009PTC068381 | Current |
| U24239MH2009PTC189566 | Previous |
Associated Brands with Lozen Pharma Private Limited
Lozen Pharma operates one associated brand: Lozen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medicated lozenges are manufactured by Lozen Pharma in Mumbai. | lozenpharma.com |
Business Activity of Lozen Pharma Private Limited
The main business activities of Lozen Pharma are manufacturing and electricity, gas, steam and air condition supply. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and electric power generation, transmission and distribution. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| D | Electricity, gas, steam and air condition supply | D1 | Electric power generation, transmission and distribution | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Lozen Pharma Private Limited
Lozen Pharma Private Limited is audited by M/s Manoj Ashra & Assiciates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M/s Manoj Ashra & Assiciates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lozen Pharma Private Limited
Lozen Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Gautam Ashra | Director | 25 Oct 2016 | 9 Years 11 Months | Current |
| Gautam Rasiklal Ashra Also directs: Anassa Realty LLP, Multiples Private Equity Fund II LLP, Organic Biosystems LLP and 5 more | Director | 11 Aug 2023 | 3 Years 1 Months | Current |
| Jugal Parekh Also directs: Tibio Innovation Solutions Private Limited | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
Financials of Lozen Pharma Private Limited FY 2025 filings available
Lozen Pharma Private Limited reported revenue of ₹47.38 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lozen Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lozen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.18 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.05 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lozen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lozen Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Lozen Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lozen Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2025 | Axis Bank Limited | ₹99.97 Lakh | Open |
| 28 Apr 2025 | Others | ₹1.81 Cr | Open |
| 21 Jun 2024 | Others | ₹11.17 Cr | Open |
| 18 Aug 2016 | Others | ₹1 Cr | Satisfied |
| 22 Dec 2011 | Karnataka State Financial Corporation | ₹45 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Lozen Pharma Private Limited
Lozen Pharma Private Limited has a workforce of 88 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Lozen Pharma Private Limited
Lozen Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCL5669C1ZD | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Lozen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lozen Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lozen Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lozen Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Lozen Pharma Private Limited
Frequently Asked Questions about Lozen Pharma Private Limited
Lozen Pharma is an active private limited company based in Savanur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2009 (17+ years old) and is registered under CIN U24239KA2009PTC068381.
Lozen Pharma reported revenue of ₹47.38 Cr for FY 2025.
Lozen Pharma has 3 current directors:
- Arjun Gautam Ashra - Director
- Gautam Rasiklal Ashra - Director
- Jugal Parekh - Director
Lozen Pharma reported a net profit of ₹1.05 Cr (net margin 2.2%) and EBITDA of ₹4.18 Cr (EBITDA margin 8.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lozen Pharma is 30% over three years and 45% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lozen Pharma is 29AABCL5669C1ZD, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Lozen Pharma is U24239KA2009PTC068381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lozen Pharma was incorporated on 14 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Bangalore.
Lozen Pharma can be reached through the website lozenpharma.com. Its registered office is in Savanur, Karnataka, India.